These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3498175)

  • 1. Antipanic drug effects during lactate infusion in lactate-refractory panic patients.
    Gorman JM; Liebowitz MR; Dillon D; Fyer AJ; Cohen BS; Klein DF
    Psychiatry Res; 1987 Jul; 21(3):205-12. PubMed ID: 3498175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate provocation of panic attacks. I. Clinical and behavioral findings.
    Liebowitz MR; Fyer AJ; Gorman JM; Dillon D; Appleby IL; Levy G; Anderson S; Levitt M; Palij M; Davies SO
    Arch Gen Psychiatry; 1984 Aug; 41(8):764-70. PubMed ID: 6742978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to sodium lactate in panic disorder: relationship to presenting clinical variables.
    Cowley DS; Dunner DL
    Psychiatry Res; 1988 Sep; 25(3):253-9. PubMed ID: 3186860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC; Garcia-Sevilla JA; Cameron OG; Smith CB
    Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996
    [No Abstract]   [Full Text] [Related]  

  • 5. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine in panic disorder patients with imipramine-associated weight gain.
    Brady K; Zarzar M; Lydiard RB
    J Clin Psychopharmacol; 1989 Feb; 9(1):66-7. PubMed ID: 2785123
    [No Abstract]   [Full Text] [Related]  

  • 7. Three cases of panic disorder with agoraphobia in children.
    Ballenger JC; Carek DJ; Steele JJ; Cornish-McTighe D
    Am J Psychiatry; 1989 Jul; 146(7):922-4. PubMed ID: 2742019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM; Rubin RT; Rifkin A; Swinson RP; Ballenger JC; Burrows GD; Dupont RL; Noyes R; Pecknold JC
    J Affect Disord; 1989; 16(1):49-58. PubMed ID: 2521651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP; Pecknold JC; Kuch K
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate vulnerability of remitted panic patients.
    Fyer AJ; Liebowitz MR; Gorman JM; Davies SO; Klein DF
    Psychiatry Res; 1985 Feb; 14(2):143-8. PubMed ID: 3887446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W; Noyes R
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of tricyclic antidepressants in panic disorder.
    Sweeney DR; Gold MS; Pottash AL; Martin D
    Int J Psychiatry Med; 1983-1984; 13(2):93-6. PubMed ID: 6642878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants.
    Noyes R; Garvey MJ; Cook BL
    J Affect Disord; 1989; 16(2-3):249-57. PubMed ID: 2522124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is buspirone effective for panic disorder?
    Sheehan DV; Raj AB; Sheehan KH; Soto S
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in the understanding and pharmacotherapy of panic attacks.
    Liebowitz MR; Fyer AJ; Gorman J; Klein DF
    Psychopharmacol Bull; 1986; 22(3):792-6. PubMed ID: 3797584
    [No Abstract]   [Full Text] [Related]  

  • 19. Panic disorder: response to sodium lactate and treatment with antidepressants.
    Rifkin A; Siris SG
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):33-8. PubMed ID: 3887490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.